openPR Logo
Press release

New date announced for SMi's Pharma Microbiology East Coast Conference

05-15-2020 10:13 AM CET | Health & Medicine

Press release from: SMi Group

microbiology, microbiologist, pharmaceutical microbiology, sterility, endoxtins, contamination control, environmental monitoring

microbiology, microbiologist, pharmaceutical microbiology, sterility, endoxtins, contamination control, environmental monitoring

SMi Reports: New highlighted and confirmed key speakers and agenda highlights summarised for Pharma Microbiology East Coast, which has now been postponed due to safety concerns over COVID-19, now taking place on October 28 and 29 2020, in Boston.

SMi's 3rd Annual Pharmaceutical Microbiology Conference will no longer take place this April. Instead, the conference new dates are October 28 and 29, 2020 at the Sheraton Boston Hotel, Boston, USA.

SPONSORED BY: Associates of Cape Cod, bioMerieux, Bioscience International, C.T.L. MAT, LONZA, Microbiologics, Millipore Sigma

The Conference will address the unique needs of pharmaceutical microbiologists and interdisciplinary scientists involved in manufacturing. It will also provide excellent opportunities to network, interact, exchange, as well as learn from industry experts and professionals from around the world.

Event Highlights:
o Discuss ongoing complication of personnel derived contaminations from the FDA
o Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel
o Learn from the perspective of the US Pharmacopeia on container closure integrity evaluation
o Examine an end-to-end contamination risk assessment for autologous cell therapy from Bristol-Myers Squibb
o Explore a back to back Genentech session covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing

Highlighted and new confirmed key speakers for 2020:
o Elia Sanchez, QC Microbiology Sr. Manager, Genentech
o Kenneth Tai, QC Scientist, Genentech
o Michael Song, Senior Manager, MedImmune
o Hilary Chan, Principal QC Scientist, Takeda
o Maria Dunnells, Sr. Manufacturing Lead Investigator, Takeda
o Austin Kuo, Principal Research Scientist, Sterility Assurance, Eli Lilly and Company
o Jim Polarine, Senior Technical Service Manager, STERIS Corporation
o Steve Walton, Sr Sterility Assurance Lead, Baxter International
o Lakiya Wimbish, Product Manager, Lonza
o Kashyap Bhatt, Senior QA Auditor, Ipsen
o Shabnam Solati, CEO, CTL-MAT
o Veronika Wills, Manager, Technical Services, Associates of Cape Cod
o Brendan Tindall, Global Solutions Manager and Program Director, bioMerieux
o Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna/ Mycosafe Consulting

SMi is pleased to announce two keynote speakers joining us, Marra Jose Lopez Barragan, CMC Product Quality Reviewer, FDA and Leslie Furr, Associate Scientific Liaison, US Pharmacopeia

There are also two interactive workshops taking place on October 30, 2020 at the Sheraton Boston hotel, USA. The two workshops are on:

Workshop A - Recombinant chromogenic assay as alternate methods for the bacterial endotoxins test (bet).
Workshop B- Mycoplasma testing by anyone, anywhere and anytime!

A new brochure with full sessions and speakers is available on event website and for those interested in attending, registration is available at www.microbiologyeastcoast.com/pr6

SPONSORED BY: Associates of Cape Cod, bioMerieux, Bioscience International, C.T.L. MAT, LONZA, Microbiologics, Millipore Sigma
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pharmaceutical Microbiology East Coast 2020
Conference: October 28th-29th, 2020
Workshops: October 30th, 2020
Sheraton Boston Hotel, Boston, USA
http://www.microbiologyeastcoast.com/pr6
#SMiPharmaMicroEC

SMi Group
45 Curlew Street
London
SE1 2ND

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New date announced for SMi's Pharma Microbiology East Coast Conference here

News-ID: 2046861 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications